02659nas a2200301 4500000000100000008004100001653001500042653002000057653001200077653001300089100001800102700001300120700001100133700001700144700001600161700001400177700001500191700001600206700001600222700001700238700001200255700001700267700008500284245007300369856009500442520180600537022001402343 2017 d10aSkindex-2910aQuality of Life10aleprosy10aColombia1 aSanclemente G1 aBurgos C1 aNova J1 aHernández F1 aGonzález C1 aReyes M I1 aCórdoba N1 aArévalo Á1 aMeléndez E1 aColmenares J1 aAriza S1 aHernández G1 aAsociación Colombiana de Dermatología y Cirugía Dermatológica (Asocolderma) 00aThe impact of skin diseases on quality of life: A multicenter study. uhttp://www.actasdermo.org/en/the-impact-skin-diseases-on/avance-resumen/S0001731016304343/3 a

INTRODUCTION: To date, no formal study has been published regarding how Colombian patients with skin disorders could be affected according to their perception of disease.

OBJECTIVE: To determine the impact in quality of life of skin diseases in a Colombian population.

METHODS: This multicenter study included patients with skin disease from almost the whole country. Individuals >18 years old; of any gender; with any skin disease and who signed informed consent, were included. We applied the Colombian validated version of the Skindex-29 instrument.

RESULTS: A total of 1896 questionnaires had sufficient information for the analyses. No significant differences in sociodemographic characteristics of patients who returned the questionnaire incomplete vs. complete, were found. Participants mean age was 41.5 years. There were no statistical differences in men vs. women regarding the global (p=0.37), symptoms (p=0.71) and emotions (p=0.32) domains, whereas statistical differences were found in the function domain (p=0.04; Mann-Whitney U test). Psoriasis, contact dermatitis, atopic dermatitis, urticaria, hair disorders, Hansen's disease, scars, hyperhidrosis and genital human papillomavirus disease scored the highest.

LIMITATIONS: Skindex-29 score variability as a result of differences in the location of the skin lesions, their inflammatory or non-inflammatory nature, and the start of therapy.

CONCLUSIONS: Even the most localized or asymptomatic skin lesion in our population leads to a disruption at some level of patient's wellness. This study adds well supported scientific data of the burden of skin diseases worldwide.

 a1578-2190